Separate names with a comma.
SEEL =Market Cap $21 M// Cash $18 M// Shares Out 6.2 M //Very attractive Pipeline including 2 potential Blockbuster in Phase 3 (Parkinson Disease...
$5 cominggg
Uuuuuuup she goes NDA acceptance news imminent ...
Clearside Biomedical, Inc. (CLSD): Outperform Candidate With 330.88% Upside Potential Clearside Biomedical, Inc. is maintained at an average...
Looks like another good day ahead ... shareholders should put a high sell limit order like $5 so your shares will not be available on the market...
NDA acceptance coming next week could push stock above $2
Major breakout to $2+ could start anytime now [IMG]
still a mega buying opportunity at this 39 million valuation which is wayy below their cash balance of $65 million .GL Presentation January 2019...
HOT stock here trading significantly below cash balance , FDA acceptance expected within days with potential FDA decision in Q3 this year . Stock...
RALLYYYYYYYYYYYYYYY NDA filings / FDA approval(s) / Important Phase 2 results and the launch of the Cannabis Products A LOT OF BIG NEWS WILL COME...
Heavily underpriced and undiscovered Cannabis Gem.. DVA.V (Market Cap $15 Million) 6 Marketed Products for Pain // 6+ CANNABIS Products to be...
IGXT = MC $49 M / $13 M Cash / FDA Decision for Migraine Drug on APRIL 1 / HOT Cannabis Play has Deal with TILRAY (TLRY) / UNDISCOVERED Stock =...
Market Cap $12 M / Cash balance $14 M / 6 Drugs awaiting FDA approval / NDA Resubmission for a BIG Pain Drug this Quarter FDA approval likely in...
AXSM = Market Cap $70 Million / Cash $41 Million or untill Q4 2019 / Shares Out 25.3 Million / 6x Phase 3 Programs in different indications...
Unknown and maybe the cheapest biotech you can get at this time . CTX has already 5 products on the market and another BIG product expect to be...
HIGH RISK Bio Stock but with significant upside potential if everything goes well . ADCOM meeting on January 10 for Lipocine´s Tlando the...
AXSM could be the next 4 - 6 bagger biotechstock https://www.tradingview.com/chart/AXSM/di8zNJvb-AXSM-could-be-the-next-4-6-bagger-biotechstock/
Looks like the runup to phase 3 results has just begun...GL "JPMorgan Chase & Co. increased its position in Axsome Therapeutics Inc (NASDAQ:AXSM)...
Looks like breakout is on the way ..2x Phase 3 readout expected within days this could push this stock noth of $10 easily ...GL [IMG]
